JANE STREET GROUP, LLC - INTRA CELLULAR THERAPIES INC ownership

Back to all holdings Add to watchlist

INTRA CELLULAR THERAPIES INC's ticker is and the CUSIP is 46116X951. A total of 3 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q1 2023$779,760
-86.1%
14,400
-86.4%
0.00%
-100.0%
Q4 2022$5,620,104
+0.8%
106,200
-11.4%
0.00%
+50.0%
Q3 2022$5,574,000
-18.1%
119,800
+0.4%
0.00%
-33.3%
Q2 2022$6,810,000–119,300–0.00%–
 Download
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q1 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 50,400$2,018,0000.03%
SIMPLEX TRADING, LLC 281$170,0000.01%
Citadel Advisors 20,300$813,0000.00%
View complete list of INTRA CELLULAR THERAPIES INC shareholders